Antibody-modified conduits for extracorporeal selective cytokine filtration in sepsis

Sepsis kills millions of people worldwide each year and occurs when microorganisms enter the bloodstream of an infected host. The presence of microorganisms in the bloodstream triggers the body to produce many inflammatory proteins, known as cytokines, that cause damage to blood vessels and vital organs. This leads to capillary leak, failing organs, and often death. We have developed a novel approach to modulate the inflammatory response, using antibody-modified conduits (AMCs) to filter harmful cytokines selectively from the circulation and in a time-specific manner. Here, we characterize variables that affect AMC performance to determine optimal AMC conditions for later use downstream.

Department dc:contributor.department

Massachusetts Institute of Technology. Department of Mechanical Engineering.

Grantor dc:publisher

Massachusetts Institute of Technology

Year dc:date.issued

2016

Author dc:creator

• Moroi, Morgan K

Advisor dc:contributor.advisor

• Robert S. Langer.

• Mechanical Engineering.

Statement dc:rights

• M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.

Licence dc:rights.uri

• http://dspace.mit.edu/handle/1721.1/7582

Language dc:language.iso

eng

Handle dc:identifier.uri

http://hdl.handle.net/1721.1/105687

OAI identifier oai:identifier

oai:dspace.mit.edu:1721.1/105687